YS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 14:40):

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer...

Stats
Today's Volume	29 131.00
Average Volume	216 712
Market Cap	137.67M
EPS	$0 ( 2024-04-19 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.310
ATR14	$0.0130 (1.76%)

Volume Correlation

Long: -0.15 (neutral)

Short: 0.25 (neutral)

Signal:(41.251) Neutral

YS Biopharma Co., Ltd. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

YS Biopharma Co., Ltd. Correlation - Currency/Commodity

-0.59
( weak negative )

-0.52
( weak negative )

0.00
( neutral )

-0.57
( weak negative )

-0.08
( neutral )

0.36
( neutral )

YS Biopharma Co., Ltd. Financials

Annual	2023
Revenue:	$687.20M
Gross Profit:	$533.84M (77.68 %)
EPS:	$-1.560

FY	2023
Revenue:	$687.20M
Gross Profit:	$533.84M (77.68 %)
EPS:	$-1.560

FY	2022
Revenue:	$502.95M
Gross Profit:	$385.88M (76.72 %)
EPS:	$-1.150

Financial Reports:

No articles found.

YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.